Cogent Biosciences, Inc. (COGT)
38.58
-0.27
(-0.69%)
USD |
NASDAQ |
Mar 02, 12:33
Cogent Biosciences EPS Diluted (Quarterly) : -0.6934 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Sarepta Therapeutics, Inc. | -3.934 |
| BridgeBio Pharma, Inc. | -0.9964 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| Revolution Medicines, Inc. | -1.855 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -102.49M |
| Total Expenses (Quarterly) | 102.49M |
| Enterprise Value | 5.733B |
| Earnings Yield | -6.35% |
| Normalized Earnings Yield | -6.259 |